vimarsana.com

Page 12 - சுவிஸ் நிதி சேவைகள் நாடகம் துடுப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

WISeKey arago AI Technology Deployed by NEORIS to Launch Smart AMS

WISeKey arago AI Technology Deployed by NEORIS to Launch Smart AMS
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

WISeKey International Holding Ltd: WISeKey Applies for Independent Identity Provider Status to Support the Swiss Federal e-ID Act

WISeKey International Holding Ltd: WISeKey Applies for Independent Identity Provider Status to Support the Swiss Federal e-ID Act An electronic identity (eID) should enable users to identify themselves correctly and securely on the internet Geneva, Switzerland - February 16, 2021: WISeKey International Holding Ltd. ( WISeKey ) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity and IoT company, today announced that it will apply to receive an independent identity provider status for its WISeID platform for the Swiss Federal Act on Electronic Identification Services (e-ID Act). Of note, the Swiss electorate is scheduled to vote on March 7, 2021 to approve the legislation introducing a federally recognized electronic identity, the e-ID, which regulates how people can be uniquely identified on the internet. Once the e-ID Act is approved, anyone who wants an e-ID must apply through a federally approved identity provider.

Investegate |Greencoat UK Wind Announcements | Greencoat UK Wind: Result of Placing

Investegate |Greencoat UK Wind Announcements | Greencoat UK Wind: Result of Placing
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Santhera Announces Corporate Update and Proposal to Strengthen Capital Structure

German NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. Pivotal 6-month data readout for vamorolone in Duchenne muscular dystrophy (DMD) expected in the second quarter of 2021 Organization streamlined with a focus on cost savings and progressing vamorolone Preliminary unaudited result for 2020: net sales CHF 15.0 million; net loss CHF 71.2 million; cash on hand as of December 31, 2020, CHF 12.4 million Upsized financing from fund managed by Highbridge Capital Management, LLC (an existing investor in the Company), to satisfy liquidity needs through the next value-inflection point Further strengthening of Santhera’s capital structure through a proposed convertible bond restructuring supported by its largest convertible bondholder representing approx. 32% of total bonds outstanding

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.